Correction to Lancet Diabetes Endocrinol 2025. Published online February 17. https://doi.org/10.1016/S2213-8587(24)00372-3

IF 44 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

The Lancet Diabetes & Endocrinology Pub Date : 2025-03-12 DOI:10.1016/s2213-8587(25)00071-3

引用次数: 0

Abstract

Munshi M, Kahkoska AR, Neumiller JJ, et al. Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies. Lancet Diabetes Endocrinol 2025; published online Feb 17 https://doi.org/10.1016/S2213-8587(24)00372-3—In this Review, the email address of the corresponding author is mmunshi@bidmc.harvard.edu. This correction has been made to the online version as of March 12, 2025.

查看原文本刊更多论文

修正柳叶刀糖尿病内分泌2025。2月17日在线发表。https://doi.org/10.1016/s2213 - 8587 (24) 00372 - 3

Munshi M, Kahkoska AR, Neumiller JJ，等。重新调整老年人糖尿病治疗方案：一个指导简化和处方策略的4S途径。柳叶刀糖尿病内分泌2025；在这篇综述中，通讯作者的电子邮件地址是mmunshi@bidmc.harvard.edu。此更正已于2025年3月12日对在线版本进行了修改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Lancet Diabetes & Endocrinology ENDOCRINOLOGY & METABOLISM-

CiteScore

61.50

自引率

1.60%

发文量

371

期刊介绍： The Lancet Diabetes & Endocrinology, an independent journal with a global perspective and strong clinical focus, features original clinical research, expert reviews, news, and opinion pieces in each monthly issue. Covering topics like diabetes, obesity, nutrition, and more, the journal provides insights into clinical advances and practice-changing research worldwide. It welcomes original research advocating change or shedding light on clinical practice, as well as informative reviews on related topics, especially those with global health importance and relevance to low-income and middle-income countries. The journal publishes various content types, including Articles, Reviews, Comments, Correspondence, Health Policy, and Personal Views, along with Series and Commissions aiming to drive positive change in clinical practice and health policy in diabetes and endocrinology.